Lomefloxacin hydrochloride

Lomefloxacin hydrochloride Basic information
Product Name:Lomefloxacin hydrochloride
Synonyms:1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylicacimonohydrochloride;bareon;ny198;sc-47111;1-ETHYL-6,8-DIFLUORO-1,4-DIHYDRO-7-[3-METHYL-1-PIPERAZINYL]-4-OXO-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE;LOMEFLOXACIN HCL;LOMEFLOXACIN HYDROCHLORIDE;Chimono
CAS:98079-52-8
MF:C17H20ClF2N3O3
MW:387.81
EINECS:627-337-1
Product Categories:Halogenated Heterocycles ,Benzothiazoles;Antibiotics for Research and Experimental Use;Biochemistry;Quinolones (Antibiotics for Research and Experimental Use);Intermediates & Fine Chemicals;Pharmaceuticals;Lomefloxacin
Mol File:98079-52-8.mol
Lomefloxacin hydrochloride Structure
Lomefloxacin hydrochloride Chemical Properties
Melting point 290-3000C
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility 1 M NaOH: soluble50mg/mL
form powder to crystal
color white to off-white
Merck 14,5562
CAS DataBase Reference98079-52-8(CAS DataBase Reference)
Safety Information
Hazard Codes Xn
Risk Statements 22
WGK Germany 3
RTECS VB1997500
HS Code 29339900
MSDS Information
ProviderLanguage
SigmaAldrich English
Lomefloxacin hydrochloride Usage And Synthesis
DescriptionLomefloxacin hydrochloride is the hydrochloride form of Lomefloxacin. Lomefloxacin is a bactericidal fluoroquinolone agent that is active against gram-negative and gram-positive organisms. Lomefloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase is thought to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV is thought to be the primary target in gram-positive organisms. The inhibition of the topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. Therefore, DNA replication and transcription is inhibited. Lomefloxacin can be used to treat many kinds of infections such as respiratory, urinary tract, obstetric, gynaecological, joint, skin, oral, ear, nose, throat and eye infections. Compared with other quinolone antibacterial drugs, lomefloxacin has certain advantages such as convenient administration and no necessity of theophylline dosage adjustment.
DescriptionLomefloxacin is an orally bioavailable, broad-spectrum fluoroquinolone antibiotic. In vitro, it inhibits growth of N. gonorrhoeae, E. coli, K. pneumoniae, P. vulgaris, S. epidermidis, and M. morganii (MIC90s = 0.1, 0.39, 0.39, 0.39, 0.39, and 0.78 μg/ml, respectively). It also inhibits growth of S. aureus and methicillin-resistant S. aureus (MRSA; MIC90 = 3.13 μg/ml for both) and of H. influenzae and ampicillin-resistant H. influenzae (MIC90 = 0.1 μg/ml for both). In vivo, lomefloxacin inhibits the growth of P. mirabilis, E. coli, K. pneumoniae, and S. aureus (ED50s = 1.39, 1.45, 1.78, and 6.66 mg/kg, respectively) in mouse models of systemic infection. It inhibits bacterial DNA gyrase, thereby inhibiting DNA synthesis and bacterial growth. Formulations containing lomefloxacin have been used in the treatment of bronchitis and urinary tract bacterial infections.
Chemical PropertiesWhite powder with no smell, bitter taste
OriginatorFoxil,Sarabhai Chemicals,India
UsesFluorinated quinolone antibacterial. DNA gyrase antagonist
DefinitionChEBI: The hydrochloride salt of lomefloxacin. It is administered by mouth to treat bacterial infections including bronchitis and urinary tract infections. It is also used topically as eye drops for the treatment of bacterial conjunctivitis, and as ear drops for he treatment of otitis externa and otitis media.
Manufacturing ProcessA mixture of 1.00 g of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3- carboxylic acid, 1.10 g of 2-methylpiperazine and 10 ml of pyridine was heated for 15 minutes under reflux. The reaction mixture was evaporated and methanol was added to the residue. The precipitate was filtered and recrystallized from ethanol to give 0.36 g of the 1-ethyl-6,8-difluoro-1,4- dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid as colorless needles, melting point 239.0-240.5°C.
By the usual manner the hydrochloride was prepared and recrystallized from water as colorless needles, melting point 290-300°C (decomp.).
Brand nameMaxaquin (Pharmacia).
Therapeutic FunctionAntibacterial
ReferencesWadworth, A. N., and K. L. Goa. "Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. " Drugs 42.6(1991): 1018-60.
Symonds, W. T., and D. E. Nix. "Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials." Clin Pharm 11.9(1992): 753-66.
Methylparaben Paraquat dichloride Methyl Isoquinoline N-Aminoethylpiperazine Acetonitrile Lomefloxacin Quinclorac Topotecan hydrochloride Basic Violet 1 Ethoxyquin 2-Ethylhexyl ferulate Lomefloxacin hydrochloride Kresoxim-methyl Methanol Methyl acrylate Dihydromyrcenol Methyl acetate

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.